Harmony Biosciences
HRMY
$31.42
Share price
-0.85%
Change (1 day)
-6.35%
Change (1 year)
Categories
Harmony Biosciences (HRMY) - P/B ratio
P/B ratio as of May 2024 : 3.85
According to Harmony Biosciences's latest financial reports the company has a price-to-book ratio of 3.85.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Harmony Biosciences - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.05 | -50.07% |
| 2022-12-31 | 8.11 | -39.31% |
| 2021-12-31 | 13.4 | -36.83% |
| 2020-12-31 | 21.2 | |
| 2019-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6522 | -83.08% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.96 | -49.17% | 🇺🇸 USA |